TNFRSF11B and supranuclear palsy, progressive, 1: To evaluate the utility of OLINK-derived biomarkers in clinical practice, we quantified the most significant proteins for differentiating between PSP and PD (TFF3, CPB1 and OPG; Table S1) by using ELISA, which is a simple and rapid technique widely used in clinical practice.